V. Tamassia

475 total citations
20 papers, 392 citations indexed

About

V. Tamassia is a scholar working on Pharmacology, Analytical Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, V. Tamassia has authored 20 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 6 papers in Analytical Chemistry and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in V. Tamassia's work include Inflammatory mediators and NSAID effects (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). V. Tamassia is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). V. Tamassia collaborates with scholars based in Italy, Switzerland and Netherlands. V. Tamassia's co-authors include L. M. Fuccella, E. Moro, Gianni Tognoni, L. Ferrario, G Corvi, F. Cavalli, M. A. Pacciarini, L. Musatti, Cristiana Sessa and M.G. Jannuzzo and has published in prestigious journals such as Biochemical Pharmacology, European Journal of Clinical Pharmacology and Cancer Chemotherapy and Pharmacology.

In The Last Decade

V. Tamassia

20 papers receiving 340 citations

Peers

V. Tamassia

PHARM

ONCOL

PHARM

CCM

J. P. Famaey Belgium

S. Erill Spain

V. Mandelli Italy

J. Roba Belgium

Herwig Eggers Switzerland

Johan Wemer Netherlands

E. Nüesch Japan

Dennis J. Chapron United States

Murray Weiner United States

P D Dawkins United States

J. P. Famaey Belgium

V. Tamassia

285 ×2.5

PHARM

68 ×0.8

ONCOL

70 ×1.1

PHARM

56 ×0.9

CCM

90 ×1.6

Citations per year, relative to V. Tamassia V. Tamassia (= 1×) peers J. P. Famaey

Countries citing papers authored by V. Tamassia

Since Specialization

Citations

This map shows the geographic impact of V. Tamassia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Tamassia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Tamassia more than expected).

Fields of papers citing papers by V. Tamassia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Tamassia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Tamassia. The network helps show where V. Tamassia may publish in the future.

Co-authorship network of co-authors of V. Tamassia

This figure shows the co-authorship network connecting the top 25 collaborators of V. Tamassia. A scholar is included among the top collaborators of V. Tamassia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Tamassia. V. Tamassia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benedetti, M. Strolin, E. Frigerio, V. Tamassia, G Noseda, & John Caldwell. (1992). The dispositional enantioselectivity of indobufen in man. Biochemical Pharmacology. 43(9). 2032–2034. 12 indexed citations

Robert, Jacques, Françoise Rigal‐Huguet, J L Harousseau, et al.. (1987). Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patients. Leukemia Research. 11(11). 961–964. 13 indexed citations

Irsigler, K, et al.. (1984). Effect of a single oral dose of acipimox on glucose utilization after intravenous glucose load in obese patients. 10. 621–625. 8 indexed citations

Cantaluppi, A., et al.. (1984). Pharmacokinetic study of the new sulfamethopyrazine-trimethoprim combination (kelfiprim) in renal insufficiency. European Journal of Clinical Pharmacology. 27(3). 345–348. 3 indexed citations

Sessa, Cristiana, et al.. (1984). Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses. Investigational New Drugs. 2(3). 281–286. 36 indexed citations

Tamassia, V., et al.. (1984). Pharmacokinetics of the enantiomers of indoprofen in man.. PubMed. 4(3). 223–30. 24 indexed citations

Willemse, Pax H.B., et al.. (1983). 253 Relation between plasma levels of medroxyprogesterone acetate and suppression of adrenal androgens. Journal of Steroid Biochemistry. 19. 84–84. 1 indexed citations

Martini, Alessandro, E. Moro, P. Marrari, et al.. (1983). Pharmacokinetics and bioavailability of metergoline in healthy volunteers after single i.v. and oral administration.. PubMed. 3(1). 27–34. 9 indexed citations

Tamassia, V., Agatino Battaglia, Fabrizio Ganzina, et al.. (1982). Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology. Cancer Chemotherapy and Pharmacology. 8(2). 151–6. 30 indexed citations

10.

Caruso, I, et al.. (1982). Bioavailability Study on a New Slow-Release Formulation of Ketoprofen. Journal of International Medical Research. 10(4). 229–233. 6 indexed citations

11.

Grasso, S., et al.. (1981). Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man. European Journal of Clinical Pharmacology. 20(2). 113–118. 3 indexed citations

12.

Musatti, L., et al.. (1981). Bioavailability and Pharmacokinetics in Man of Acipimox, a New Antilipolytic and Hypolipemic Agent. Journal of International Medical Research. 9(5). 381–386. 28 indexed citations

13.

Caruso, I, et al.. (1980). Plasma and Synovial Fluid Pharmacokinetics and Prostaglandin Inhibitory Effect of Indoprofen in Patients with Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 9(2). 123–126. 13 indexed citations

14.

Tamassia, V., et al.. (1979). Indobufen (K 3920), a new inhibitor of platelet aggregation: Effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man. European Journal of Clinical Pharmacology. 15(5). 329–333. 18 indexed citations

15.

Fuccella, L. M., et al.. (1979). Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man. European Journal of Clinical Pharmacology. 15(5). 323–327. 23 indexed citations

16.

Fuccella, L. M., et al.. (1977). Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. European Journal of Clinical Pharmacology. 12(5). 383–386. 81 indexed citations

17.

Tamassia, V., et al.. (1976). Pharmacokinetics and bioavailability of indoprofen in man. European Journal of Clinical Pharmacology. 10(3-4). 257–262. 14 indexed citations

18.

Tamassia, V.. (1975). The pharmacokinetics and bioavailability of glipizide. Current Medical Research and Opinion. 3(sup1). 20–30. 7 indexed citations

19.

Fuccella, L. M., et al.. (1973). Metabolism and Kinetics of the Hypoglycemic Agent Glipizide in Man—Comparison with Glibenclamide. PubMed. 13(2-3). 68–75. 44 indexed citations

20.

Fuccella, L. M., et al.. (1973). Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man. European Journal of Clinical Pharmacology. 6(4). 256–260. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact